IRIS
PISTELLI, MIRCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.858
EU - Europa 715
AS - Asia 650
SA - Sud America 116
AF - Africa 64
Continente sconosciuto - Info sul continente non disponibili 52
OC - Oceania 3
Totale 3.458
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.831
SG - Singapore 214
IT - Italia 172
CN - Cina 137
VN - Vietnam 129
RU - Federazione Russa 108
BR - Brasile 89
SE - Svezia 77
IE - Irlanda 71
DE - Germania 66
UA - Ucraina 60
HK - Hong Kong 45
CI - Costa d'Avorio 43
GB - Regno Unito 41
FR - Francia 40
BD - Bangladesh 34
FI - Finlandia 26
TR - Turchia 24
IN - India 21
CA - Canada 15
DK - Danimarca 14
PL - Polonia 12
KR - Corea 11
AR - Argentina 10
JP - Giappone 10
MX - Messico 9
MA - Marocco 7
ZA - Sudafrica 7
CO - Colombia 5
ES - Italia 5
NL - Olanda 5
BE - Belgio 4
CL - Cile 4
IQ - Iraq 4
KE - Kenya 4
PK - Pakistan 4
AT - Austria 3
AU - Australia 3
EC - Ecuador 3
JO - Giordania 3
AL - Albania 2
CH - Svizzera 2
EU - Europa 2
LB - Libano 2
RO - Romania 2
UZ - Uzbekistan 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
BH - Bahrain 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
HU - Ungheria 1
ID - Indonesia 1
JM - Giamaica 1
LT - Lituania 1
MD - Moldavia 1
MM - Myanmar 1
NI - Nicaragua 1
NP - Nepal 1
OM - Oman 1
PH - Filippine 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PY - Paraguay 1
QA - Qatar 1
SR - Suriname 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
UY - Uruguay 1
Totale 3.408
Salva come PNG Salva come JPEG
Città #
Ashburn 310
Chandler 170
Singapore 130
Dallas 121
San Jose 113
Jacksonville 90
Fairfield 80
Dublin 70
New York 68
Boardman 56
Des Moines 55
Council Bluffs 46
Houston 44
Abidjan 43
Hong Kong 42
Beijing 40
Woodbridge 40
Ho Chi Minh City 39
Seattle 39
Wilmington 38
Hanoi 32
Los Angeles 31
The Dalles 30
Cambridge 27
Lawrence 22
Munich 22
Princeton 22
Ann Arbor 21
Rome 21
Moscow 20
San Mateo 20
Lauterbourg 17
Centro 15
Chicago 13
Turku 13
Buffalo 12
London 12
San Diego 12
São Paulo 12
Orem 11
Santa Clara 11
Milan 10
Turin 10
Warsaw 10
Washington 10
Montreal 8
Porto 8
Da Nang 7
Hefei 7
Stockholm 7
Tokyo 7
Boston 6
Cagliari 6
Frankfurt am Main 6
Haiphong 6
Helsinki 6
Phoenix 6
Ancona 5
Brooklyn 5
Cantu 5
Chennai 5
Chiaravalle 5
Denver 5
Falls Church 5
Guangzhou 5
Mexico City 5
Pune 5
Ankara 4
Brasília 4
Brussels 4
Johannesburg 4
New Delhi 4
Nonantola 4
Poplar 4
Prescot 4
Rio de Janeiro 4
Amman 3
Atlanta 3
Birmingham 3
Biên Hòa 3
Bắc Ninh 3
Campinas 3
Columbus 3
Falconara Marittima 3
Hải Dương 3
Kilburn 3
Manchester 3
Miano 3
Mumbai 3
Nairobi 3
Salt Lake City 3
San Francisco 3
Shenzhen 3
Thái Nguyên 3
Wuhan 3
Yiwu 3
Arcene 2
Bogotá 2
Calgary 2
Caserta 2
Totale 2.304
Salva come PNG Salva come JPEG
Nome #
Role of DCE-MR in predicting breast cancer subtypes. 191
Long‑responders to anti‑HER2 therapies: A case report and review of the literature 174
Body Mass Index and Hormone Receptor Status Influence Recurrence Risk in HER2-Positive Early Breast Cancer Patients 172
Prospective observational study of taste assay in patients with solid tumors treated with standard chemotherapy (POTATO) 170
Pre-treatment neutrophil to lymphocyte ratio may be a useful tool in predicting survival in early triple negative breast cancer patients 169
Androgen receptor expression in early triple-negative breast cancer: clinical significance and prognostic associations. 168
Role of DCE-MR imaging of the breast in predicting breast cancer subtypes: where are we going? 163
The impact of lifestyle interventions in high‐risk early breast cancer patients: A modeling approach from a single institution experience 159
Adjuvant capecitabine in triple negative breast cancer patients with residual disease after neoadjuvant treatment: real-world evidence from CaRe, a multicentric, observational study 151
Irinotecan-Induced Transient Dysarthria: Case Series and Updated Literature Review 150
Allele polymorphisms of tumor integrins correlate with peritoneal carcinosis capability of gastric cancer cells in radically resected patients. 142
Paclitaxel and Bevacizumab in First Line-Treatment Patients with HER-2 Negative Advanced Breast Cancer: Who could Benefit? 139
A Mixed-apprOach program To help women wIth breast cancer stay actiVE (MOTIVE program): A pilot-controlled study 137
Palbociclib plus endocrine therapy in HER2 negative, hormonal receptor-positive, advanced breast cancer: A real-world experience 136
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence 136
Everolimus and exemestane in long survival hormone receptor positive male breast cancer: case report 135
Expectations and psychological issues before genetic counseling: analysis of distress determinant factors 135
Three drugs vs two drugs first-line chemotherapy regimen in advanced gastric cancer patients: a retrospective analysis 132
Comparison Between Alendronate and Denosumab in Preventing Bone Loss and Lowering Fracture Risk Related to Adjuvant Endocrine Therapy for Breast Cancer: Real-World Data From a Third-Level Center Experience 128
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting 125
Healthcare cost of HER2-positive and negative breast tumors in the United States (2012–2035) 124
Efficacy and safety of Everolimus and Exemestane in hormone-receptor positive (HR+) human-epidermal-growth-factor negative (HER2−) advanced breast cancer patients: New insights beyond clinical trials. The EVA study 117
Espressione di p-mTOR e del recettore degli androgeni nei tumori mammari triplo negativi: significato clinico e potenziali prospettive terapeutiche 105
Adjuvant Systemic Therapy in DCIS 100
Totale 3.458
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.231
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.231
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022172 0 28 4 1 2 29 11 9 17 22 17 32
2022/2023455 31 58 30 49 27 99 0 15 97 2 24 23
2023/2024242 46 3 16 17 33 70 4 16 0 3 0 34
2024/2025415 65 45 11 9 24 12 35 10 74 22 55 53
2025/20261.508 120 94 149 167 178 109 227 126 107 106 69 56
2026/202765 37 28 0 0 0 0 0 0 0 0 0 0
Totale 3.458